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Objectives: To characterize a CTX-M-15-producing Klebsiella pneumoniae isolate that was identified during an
outbreak involving 16 patients who had undergone endoscopic retrograde cholangiopancreatography between
December 2008 and August 2009. The strain was also detected in one endoscope used for these examinations.
Methods: Disc diffusion assays, MICs and isoelectric focusing were used to characterize the plasmidic CTX-M-15
b-lactamase. PCRs were used to check for the presence of genes associated with virulence or antibiotic resist-
ance. Antibiotic tolerance tests and plasmid transfer were carried out in both planktonic and biofilm conditions.
Results: The strain belonged to sequence type 14 and to the virulent capsular serotype K2, but produced little
glucuronic acid. It contained a 62.5 kb conjugative plasmid carrying the blaCTX-M-15, blaOXA-1 and aac(6′)-Ib-cr
genes and harboured few virulence genes (uge, wabG, kfu and mrkD). The strain was highly resistant to cefo-
taxime (MIC 516 mg/L) and the presence of this antibiotic at sub-MIC concentrations enhanced biofilm forma-
tion. The isolate was susceptible to ofloxacin (MIC 2 mg/L), but the bactericidal effect of this antibiotic was
greater in planktonic cultures and 6 h old biofilm than in 24 or 48 h old biofilms. The K. pneumoniae strain
was notable for its ability to transfer its plasmid, especially in biofilm conditions, in which the rate of
plasmid transfer was about 0.5/donor.
Conclusions: These findings demonstrate the ability of this strain to survive in a hospital environment and to
transfer its extended-spectrum b-lactamase-encoding plasmid.
Keywords: Enterobacteriaceae, extended-spectrum b-lactamases, ST14
Introduction
In their natural environment, bacteria not only exist as isolated
cells but also grow and survive in organized communities
termed biofilms, where they are kept together by a self-produced
biopolymer matrix. Biofilm growth occurs on natural surfaces,
such as the teeth, heart valves and lungs, but also on indwelling
medical devices, such as prosthetic joints, endoscopes and intra-
venous catheters.1 Medical devices are typically contaminated by
organisms that comprise the natural flora surrounding the site of
material insertion. Microorganisms growing in biofilms exhibit
phenotypic characteristics that are distinct from those of plank-
tonic organisms, including increased resistance to host immune
defences and to antimicrobial compounds.2 The molecular
nature of this resistance has not been fully elucidated. The
resistance could be due to the slowly growing state of the cells
in the deeper layers of thick biofilms, which have less access to
antibiotics and nutrients, and to the impaired diffusion of anti-
microbial molecules within the biofilms.3 There is increased hori-
zontal gene transmission in biofilms, with high plasmid transfer
rates,1,4 which aggravates the problem of resistance. The close
proximity of bacterial cells in biofilms creates an environment
conducive to the exchange of genetic material, especially via
conjugative pili.5
Klebsiella pneumoniae is a Gram-negative pathogen involved
in hospital outbreaks of nosocomial infections, causing
bloodstream, biliary tract and other infections.6,7 K. pneumoniae
isolates are frequently resistant to broad-spectrum cephalospor-
ins, due to the production of extended-spectrum b-lactamases
(ESBLs),8 evidence of the role of K. pneumoniae as a reservoir
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for plasmids carrying antibiotic resistances genes. Over the last
few decades the prevalence of ESBL-producing Enterobacteria-
ceae has increased worldwide, mainly due to the dissemination
of Escherichia coli and K. pneumoniae producing CTX-M-type
ESBLs. CTX-M-15 is the most widespread CTX-M type, and
the predominant type in various countries.9 In addition,
K. pneumoniae produces a number of virulence factors that
contribute to pathogenesis, including a thick polysaccharide
capsule (which is considered to be the dominant virulence prop-
erty), fimbrial and non-fimbrial adhesins and siderophores.10–13
Epidemiological studies have shown that the gastrointestinal
tract is colonized before infection and therefore constitutes a
reservoir for K. pneumoniae.14 The infections are often linked to
the use of invasive medical devices.
Between December 2008 and August 2009, 16 patients at the
teaching hospital of Clermont-Ferrand, France, were identified as
having an ESBL-type CTX-M-15-producing K. pneumoniae; there
were eight bloodstream infections, four biliary tract infections
and four faecal carriages. All of the patients had previously
undergone endoscopic retrograde cholangiopancreatography
(ERCP). The strain was also detected in the inner channels of
one endoscope used for ERCP despite its being cleaned and
dried after use.15 The endoscope had probably been contami-
nated by one patient’s intestinal tract flora and thereafter
caused the strain to spread. The clonal relatedness of all the iso-
lates was shown by PFGE.15
In this study, we investigated several virulence factors of this
particular isolate of K. pneumoniae, assessed its ability to form
biofilm in the presence of subinhibitory concentrations of two
major antibiotics (cefotaxime and ofloxacin) and measured the
conjugative rates of its CTX-M-15-encoding plasmid in biofilm
versus planktonic cultures.
Materials and methods
Bacterial strains, growth conditions and determination
of hypermucoviscosity phenotype
Clinical isolate K. pneumoniae LM21 was used as control in biofilm and
bile challenge assays and in measurements of growth and adhesion to
epithelial cells.16 All bacterial strains were stored at 2208C and 2808C
in lysogeny broth (LB) medium containing 20% glycerol. Strains were
grown in LB or Mueller–Hinton (MH) broth or agar at 378C for 18–24 h.
When needed, media were supplemented with relevant antibiotics:
ofloxacin (0.1–8 mg/L), cefotaxime (1–1024 mg/L), streptomycin
(50 mg/L) and ceftazidime (2 mg/L). Bacterial growth was monitored by
measuring the optical density (OD) at 620 nm, and the numbers of cfu
were quantified by plating serial dilutions of the suspension on LB agar
plates. To examine bacterial growth in vitro, bacterial strains were
grown in LB, diluted 1: 100 into fresh broth and shaken for 7 h. Values
for the OD of each sample were recorded at regular intervals. The isolates
were classified phenotypically as mucoid or non-mucoid by the colony
loop lift test. Mucoid phenotype was defined as being present when a
string-like growth was observed to attach to the loop as it was lifted
from the plate.17
Characterization of the b-lactamases: susceptibility to
b-lactams, isoelectric focusing and MICs
Antibiotic-containing discs (ampicillin, amoxicillin/clavulanate, ticarcillin,
ticarcillin/clavulanate, piperacillin, piperacillin/tazobactam, cefalotin,
cefuroxime, cefoxitin, ceftazidime, cefotaxime, ceftriaxone, aztreonam,
cefepime, imipenem, ertapenem, meropenem, nalidixic acid, norfloxacin,
ciprofloxacin, tobramycin, gentamicin, netilmicin, amikacin, tetracycline,
co-trimoxazole, chloramphenicol, colistin and tigecycline) were used for
antibiotic susceptibility testing by the disc diffusion assay (MAST Diagnos-
tic, Amiens, France). Results of susceptibility testing were analysed
according to the recommendations of the Comite´ de l’Antibiogramme
de la Socie´te´ Franc¸aise de Microbiologie (CA-SFM).18
Isoelectric focusing of b-lactamases was performed with polyacryl-
amide gels containing ampholines with a pH range of 3.5–10.0, as pre-
viously described,19 with TEM-39 (pI 5.2), TEM-1 (pI 5.4), TEM-2 (pI
5.6), SHV-1 (pI 7.7), CTX-M-15 (pI 8.6) and CMY-4 (pI 9) as standards.
MICs of ofloxacin and cefotaxime were determined by a microdilution
method and interpreted according to guidelines of CA-SFM.18
PCRs
PCRs were performed to check for the presence of genes (magA, allS,
rmpA, kfu, cf29a, fimH, uge, wabG20 and mrkD21) associated with viru-
lence in K. pneumoniae. Genomic DNA from strains NTUH-K2044,17
KP5214522 and MGH 78578 were used as controls. Primers ORF
1907-1908.1 and ORF 1907-1908.2 were used to check for the presence
of colibactin.23 Primers CTX-M-1A and CTX-M-1B, and OXA-1A and
OXA-1B were used to amplify and sequence blaCTX-M-15 and blaOXA-1
genes, respectively, as previously described.24 Primers AAC6′-A and
AAC6′-B25 were used to amplify and sequence the aac(6′) gene.
Multilocus sequence typing (MLST) was performed as described by
Diancourt et al.26 (http://www.pasteur.fr/recherche/genopole/PF8/mlst/
Kpneumoniae.html).
Preparation of plasmid DNA
Plasmid extractions of clinical isolates and transconjugants were per-
formed by the method of Kado and Liu.27 The size of the plasmid was
estimated by comparing their electrophoretic mobilities with those of
known reference plasmids.
Extraction, quantification and genotyping of capsular
polysaccharides (cps)
Bacterial strains were grown in LB and cps were extracted with Zwitter-
gent 3–14 detergent. The amount of glucuronic acid was then measured
according to the method described by Domenico et al.28 In parallel, serial
dilutions of the bacterial culture were plated to determine the number of
cfu, and the concentration of cps was expressed according to the
amount of glucuronic acid (mg) for 109 cfu per mL of sample. Each experi-
ment was performed in triplicate.
cps genotyping was performed by PCR detection of K serotype-specific
alleles wzy and wzx loci as previously described to identify K1 and K2
alleles.17 Strains NTUH-K2044 and KP52145 were used as positive
controls.
Biofilm assays
We used a slightly modified version of the microtitre plate assay devel-
oped by O’Toole and Kolter.29 Briefly, 4 mL of overnight culture was inocu-
lated into 100 mL of M63B1 in a 96-well culture-treated polystyrene
microtitre plate (Nunc) with or without antibiotics. Wells filled with
growth medium alone were included as negative controls. After 3 h of in-
cubation at 378C, surface-adherent biofilm formation was measured by
staining bound cells for 15 min with a 0.5% (w/v) aqueous solution of
crystal violet. After rinsing with distilled water, the bound dye was
released from the stained cells using 95% ethanol, and OD at 590 nm
was determined.
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Cell cultures and adhesion assays
Intestine-407 (Int-407) cells derived from human embryonic jejunum
and ileum were cultivated as described elsewhere and adhesion to the
different cell lines was assayed as described previously.30 These experi-
ments were performed in triplicate.
Biological assay for siderophore production
Lawn of the bacterial strain LG152231 was grown on appropriate M9
minimal agar containing a,a′ dipyridyl. Strains to be tested were inocu-
lated onto the lawn and incubated at 378C overnight. Aerobactin produc-
tion was detected as a halo of growth of the indicator strain around an
inoculum.
Bile challenge assay
For the growth assay, 5 mL of LB broth with or without the addition of
10% of crude ox bile extract (Sigma) was inoculated with cells from an
overnight culture to reach 4×107 cfu/mL. The cultures were incubated
aerobically with shaking for 5 h and the numbers of viable bacteria
were determined. The results are expressed as the ratio of the number
of cfu obtained from LB cultures containing 10% of bile to the number
of cfu obtained from control cultures (LB alone).
Antibiotic tolerance testing
The ability of bacteria to resist antibiotics in biofilm cultures was studied
with ofloxacin according to a slightly modified method of Zuroff et al.32
Briefly, the colony biofilm systems consisted of MH agar plates, sterile
0.22 mm pore nitrocellulose membranes (Millipore) and the bacteria.
The membrane was inoculated with 100 mL of an exponentially
growing culture (diluted to OD620¼ 0.1). The culture was grown for 6,
24 or 48 h and the inoculated membrane was then transferred either
to a plate containing the tested antibiotic at different concentrations
(ofloxacin at 0.1, 1, 2 and 4 mg/L) or to a control plate for an additional
24 h. After incubation, some of the colony biofilms were aseptically trans-
ferred to tubes pre-filled with 5 mL of sterile PBS. The colony biofilm was
vortexed vigorously for 1 min to separate the cells from the membrane
and homogenized for 5 min using an ultrasonic bath. The culture was
then serially diluted and the numbers of cfu per membrane were deter-
mined. Each experiment was performed in triplicate. The other biofilms
were coloured with Live/Deadw Fixable Dead Cell Stain kits (L-7012, Invi-
trogen), according to the manufacturer’s instructions, and analysed by
confocal microscopy. The biofilm sample was observed with an LSM510
Meta microscope (Carl Zeiss MicroImaging, Inc., le Pecq, France) with a
40XNA 1.3 Plan-Neofluar lens. All imaging was performed at room
temperature. Figures were processed using Fiji Image Browser software
(http://pacific.mpi-cbg.de/wiki/index.php/Main_Page).
In parallel, the ability of bacteria to resist antibiotics in planktonic cul-
tures was studied according to the method of Zuroff et al.32 with the
same antibiotic at similar concentrations and the same range of bacterial
inocula. Briefly, 50 mL cultures were grown exponentially for 6 h with
shaking at 378C in MH broth. The cells were collected by centrifugation
and resuspended in 50 mL of fresh medium containing different concen-
trations of ofloxacin or in control medium for another 24 h at 378C with
shaking. The viable cell counts were determined using serial dilutions and
enumerations. Each experiment was performed in triplicate. We calcu-
lated the logarithmic reductions (log10 cfu) between the bacterial
numerations of the control culture and the bacterial numerations after
the action of ofloxacin. The mean logarithmic reductions were calculated
for each experiment and compared by the Mann–Whitney test. The sig-
nificance level was set at 0.05. Analyses were performed with SAS (SAS
Institute Inc.).
The effect of cefotaxime and ofloxacin on the formation of biofilm
was studied in microtitre plates as described above using concentrations
of cefotaxime or ofloxacin ranging from 1 to 64 mg/L or 0.5 to 8 mg/L,
respectively.
Transfer of plasmids
In planktonic conditions, conjugation experiments were carried out as
previously described.33 Briefly, 108 cfu of overnight culture of donor
(CTX-M-15-producing K. pneumoniae) and recipient (a streptomycin-
resistant mutant of E. coli MG1555) strains were inoculated into
1000 mL of LB broth for 3 h. In biofilm conditions, conjugation experi-
ments were carried out on LB agar and sterile 0.22 mm pore nitrocellulose
filters (Millipore) with the same inoculum.34 After 3 h of incubation, the
colony biofilms were harvested and bacteria resuspended in saline by
vortexing and sonication. Transconjugants and donor strains were
selected and quantified on LB agar containing streptomycin (50 mg/L)
and ceftazidime (2 mg/L) and on LB agar containing ceftazidime (2 mg/L),
respectively. Each experiment was performed in triplicate.
Results and discussion
CTX-M-15-producing K. pneumoniae
Susceptibility results
The strain was resistant to all penicillins alone or in combination
with b-lactamase inhibitors (clavulanate and tazobactam), to
cefalotin, cefuroxime, ceftazidime, cefotaxime, ceftriaxone,
aztreonam and cefepime. It was susceptible to cefoxitin, imipe-
nem, ertapenem and meropenem. The double disc diffusion test
confirmed the production of an ESBL.15 The strain was also
intermediate or resistant to nalidixic acid and norfloxacin, all
aminoglycosides except gentamicin, and to tetracycline and co-
trimoxazole. It was susceptible to ciprofloxacin, chloramphenicol,
colistin and tigecycline. Isoelectric focusing showed that the
strain produced two b-lactamases of pI 7.5 and 8.6. PCR and se-
quencing experiments identified these two enzymes as the peni-
cillinases OXA-1 and CTX-M-15, respectively. A gene encoding
AAC(6′)-Ib-cr was also detected in the strain’s genome.
Plasmid content analysis revealed the presence of one plasmid,
with an approximate size of 61.5 kb (data not shown).
Virulence and strain typing
This CTX-M-15-producing strain was further characterized in
order to determine its background specificities, including the
presence of virulence-associated genes and its genotype. It har-
boured the genes wabG and uge, which encode proteins that
play a role in colonization and virulence through their involve-
ment in lipopolysaccharide synthesis.35 Gene mrkD was also
detected, which encodes type 3 fimbrial adhesin,36 known to
play a role in biofilm formation. Gene fimH, which encodes
type 1 fimbrial adhesin, and gene kfu, which encodes a Klebsiella
ferric iron uptake system that leads to higher virulence in a
mouse model, were also present in the genome of this
isolate.22 These virulence genes are widespread among K. pneu-
moniae strains.20 Specific cps PCRs indicated that the strain
belonged to serotype K2, which is associated with virulence.
MLST resulted in sequence type 14, which has already been
linked to CTX-M-15-producing K. pneumoniae,37,38 and seems
to be well adapted to survival in the hospital environment and
Klebsiella pneumoniae CTX-M-15 and biofilm
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able to gather resistance genes. However, extraction and quan-
tification of cps showed that the isolate was a low glucuronic
acid producer (,5 mg/0.5 mL of overnight culture) and no hyper-
mucoviscosity phenotype was observed. No other virulence gene
markers were detected. Under iron-deprived conditions of
growth, no cross-feeding was observed with strain LG1522,31
demonstrating the absence of expression of the aerobactin
iron uptake system. We then compared the isolate with the la-
boratory non-ESBL-producing K. pneumoniae LM21. Their rates
of growth in LB broth were similar, suggesting the absence of
fitness cost due to the ESBL. Using a microtitre plate experimen-
tal model, we showed that both strains formed biofilm with a
similar biomass (data not shown). No significant difference was
observed between the two strains in the bile resistance assay.
However, the CTX-M-15-producing K. pneumoniae strain
adhered 1.8-fold (+0.09) more to Int-407 cells than strain
LM21 (P¼ 0.001).
These results are consistent with the clinical observations of
Aumeran et al.,15 who found the clinical isolate of K. pneumoniae
in 16 patients contaminated by the endoscopes. It is therefore
likely that the strain’s ability to form biofilm contributed to con-
tamination of the endoscopes and that its ability to adhere to
epithelial cells favoured colonization of the patients’ gastro-
intestinal tract. However, although belonging to the virulent
serotype K2, the strain was not considered clinically virulent
since no death was reported and some patients did not need
to be treated despite having bacteraemia. Indeed, the link
between antibiotic resistance and virulence is complex. In
most cases, CTX-M production has been observed in E. coli
with few virulence factors or causing minor infections,39–41
but in some reports the strains have been associated with
high virulence expression.42,43 Although the strain isolated in
our study was highly resistant to antibiotics and exhibited
colonization properties, its low virulence level probably pre-
vented an outbreak of more severe infections.
Properties of the CTX-M-15-producing K. pneumoniae
strain in biofilm versus planktonic cultures
The primary source of the epidemic strain was most likely the gut
of the patients, with cross-contamination to patients who subse-
quently underwent endoscopy.15 The strain’s ability to initially
form biofilm on such devices and the detachment of cell
clumps from biofilm aggregates during the clinical investigation
was probably responsible for contamination. Since most patients
were receiving antibiotics, we assessed, in addition to the deter-
mination of MICs with planktonic bacteria, the behaviour of
biofilm forms of this isolate in the presence of antibiotics.
Antibiotic killing rate
The bactericidal effects of cefotaxime and ofloxacin, two antibio-
tics frequently used in the treatment of infectious diseases, were
determined on sessile bacteria using 6, 24 and 48 h old biofilms.
The percentage of surviving cells showed that ofloxacin at con-
centrations of 1, 2 and 4 mg/L (MIC/2, MIC and 2×MIC, respect-
ively) was far less effective against 24 and 48 h old biofilms than
6 h old biofilm or planktonic cultures (Figure 1). Confocal scan-
ning microscopy observation of 24 h old biofilms indicated that
a majority of bacteria in contact with a sub-MIC antibiotic
(1 mg/L, MIC/2) were dead (red) and mostly at the bottom of
the biofilm, i.e. at the closest point between bacteria and the
antibiotic contained in the agar medium (Figure 2a). In contrast,
without ofloxacin almost all the bacteria were alive (green)
(Figure 2b).
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Figure 1. Bacterial logarithmic reductions of biomass (cfu) after action of ofloxacin (0.1, 1, 2 or 4 mg/L; MIC of ofloxacin for this strain, 2 mg/L) on
planktonic cells and on 6, 24 or 48 h old biofilms. *P≤ 0.05: comparison by a Mann–Whitney test of mean logarithmic reductions between
planktonic and 24 or 48 h biofilm cultures.
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Figure 2. Confocal laser scanning microscopy images: Live/Deadw coloration of 24 h old biofilm formed in the presence (a) or in the absence (b) of
ofloxacin at a concentration of 1 mg/L (sub-MIC) with the Live/Deadw kit. The bottom (‘b’) portion is in contact with the nitrocellulose membrane on
the MH agar.
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Sessile bacteria have increased levels of resistance to antibio-
tics, with the MICs of antimicrobial agents 100- to 1000-fold
higher than for bacteria in planktonic form.11 This increased re-
sistance occurs mainly in mature biofilms and is attributed to
the formation of antibiotic-resistant or -tolerant subpopulations
in the deeper layers of mature biofilms in combination with
impaired molecule diffusion.3 Mature biofilm of CTX-M-15-
producing K. pneumoniae was established after 24 h in this
experimental setting, and no significant difference in antibiotic
resistance was observed between 24 and 48 h old biofilms, sug-
gesting that the impaired killing mechanism occurred after 24 h
of biofilm maturation.
We then studied the effect of cefotaxime and ofloxacin on the
formation of biofilm. In the presence of sub-MICs of ofloxacin,
the biomass decreased and was inversely related to the antibiotic
concentrations (Figure 3a). In contrast, when the cefotaxime
concentration of the antibiotic increased, so did the biofilm
biomass (Figure 3b). Since all concentrations tested were at
least 4-fold lower than the MIC, we can infer that subinhibitory
concentrations of this antibiotic enhance biofilm formation. The
induction of biofilm formation by b-lactams, such as imipenem
and ceftazidime, has already been observed with Pseudomonas
aeruginosa in association with an increase in alginate
production.44 Balasubramanian et al.45 have shown the exist-
ence of a co-regulatory network between b-lactam resistance,
alginate production, quorum-sensing and virulence factor pro-
duction, with AmpR playing a central role. ampR is not present
in the genome of K. pneumoniae strains, but a previous study
from our laboratory showed that type 2 quorum sensing plays
a role in biofilm formation46 and could therefore be involved in
this process through another regulator.
Transfer of plasmids
K. pneumoniae is known to contain many plasmid-mediated re-
sistance determinants and to favour the spread of these anti-
biotic resistances in the hospital environment and hence we
decided to study the plasmid transfer ability of this particular
isolate in planktonic and biofilm conditions.
In planktonic cultures, the transfer rate of the plasmid
harbouring the CTX-M-15 gene was about 1023/donor.
Sandegren et al.47 were able to transfer the CTX-M-15-producing
plasmid pUUH239.2 via conjugation to laboratory strains of
E. coli, but with lower frequencies (5×1026–3×1028/donor).
In our study, plasmid transfer occurred at a higher frequency
in biofilm cultures, reaching the value of 0.5/donor. Gene transfer
by plasmid conjugation and transformation has been found to
occur frequently and effectively in many bacterial biofilms,
both in natural environments and in more artificial settings.4
One explanation could be that the conjugative pili act as cell
adhesins, which connect the cells and stabilize biofilm structure.
It is noteworthy that the presence of the plasmid in transconju-
gant E. coli did not increase its ability to form biofilm (data not
shown), suggesting that the plasmid does not carry genes
involved in biofilm formation.
Conclusions
In conclusion, our study provides new information about the
K. pneumoniae strains involved in clinical infections, in particular
their ability and that of their conjugative plasmids to spread. It is
likely that the CTX-M-15 plasmid ended up in a K. pneumoniae
strain that is particularly able to disseminate, but relatively non-
virulent. The antibiotic resistance genes harboured by this
plasmid may have given the strain a selective advantage for suc-
cessful survival in a hospital environment.
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